Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01760720
Other study ID # R01DA033130
Secondary ID
Status Completed
Phase N/A
First received January 2, 2013
Last updated July 24, 2017
Start date March 2012
Est. completion date December 2015

Study information

Verified date July 2017
Source University of California, Los Angeles
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Based on our previous success with the intervention pilot (R34MH083512), we conducted this randomized controlled trial (MMT CARE), which will integrate behavioral intervention components with a primarily pharmacological model of MMT. The intervention focuses on treatment adherence and effective outcomes by reducing stigmatizing attitudes and behaviors among service providers, enhancing their communication skills, and improving their interactions with and support of their clients' behavior changes. Our goal is to bring a contextual change to support a protective environment for clients' motivation and capacity in order to reduce their HIV risk. The findings could benefit not only China but also the global community by effectively combining interventions for controlling the HIV epidemic.


Description:

Injecting drug use is the major mode of HIV transmission for 740,000 people living with HIV (PLH) in China. In response to this situation, China introduced methadone maintenance treatment (MMT) in 2004, which is now dispensed by 701 clinics serving 295,000 clients. Despite this impressive scale-up, China's MMT programs still face serious challenges, including high drop-out rates, a large number of clients who continue to use heroin during MMT, a gap between clients' needs and services availability, providers' lack of skills in counseling and education, and stigma linked to resistance to harm reduction. This study aims to address these challenges.

Based on our previous success with the intervention pilot (R34MH083512), we conducted this randomized controlled trial (MMT CARE), which will integrate behavioral intervention components with a primarily pharmacological model of MMT. The intervention focuses on treatment adherence and effective outcomes by reducing stigmatizing attitudes and behaviors among service providers, enhancing their communication skills, and improving their interactions with and support of their clients' behavior changes. Our goal is to bring a contextual change to support a protective environment for clients' motivation and capacity in order to reduce their HIV risk. The findings could benefit not only China but also the global community by effectively combining interventions for controlling the HIV epidemic.

The study will be implemented in Sichuan, Guangdong, Hunan, Shaanxi and Jiangsu provinces. A total of 68 MMT clinics will be randomly selected from the five provinces and randomized to either the intervention condition (MMT CARE group) or the control condition. From each selected clinic, we will recruit 6 service providers and 36 clients, totaling 408 service providers and 2,448 clients (204 service provider and 1,224 clients in each condition, respectively).

The Specific Aims of the study are as follows:

1. To examine whether providers in the intervention group, compared to providers in the control group, demonstrate improved adherence to MMT protocols, decreased prejudicial attitudes, increased interactions with clients, and increased communications with clients on risk reduction.

2. To examine whether MMT clients in the intervention group, compared to clients in the control group, demonstrate improved treatment adherence/retention, decreased concurrent drug use, increased motivation for behavior change, improved mental health, increased positive support, and reduced HIV risk behaviors.

3. To explore whether providers' improved outcomes are associated with improved client outcomes.


Recruitment information / eligibility

Status Completed
Enrollment 2866
Est. completion date December 2015
Est. primary completion date December 2015
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

MMT clients

- Age 20 and above

- Currently enrolled in MMT at the participating clinics

- Informed consent Service providers

- Age 18 and above

- Currently working in the participating MMT clinics

- Informed consent

Exclusion Criteria:

MMT Clients

- Psychosis, neurological damage, as judged by an interviewer in consultation with a clinical supervisor

- Currently under criminal or civil charges

- Inability to give informed consent

- Anyone who does not meet the inclusion criteria

Service Providers

- Inability to give informed consent

- Anyone who does not meet the inclusion criteria.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
MMT CARE


Locations

Country Name City State
China China CDC, NCAIDS Beijing

Sponsors (1)

Lead Sponsor Collaborator
University of California, Los Angeles

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Client treatment retention MMT retention will be measured by the treatment status (in treatment vs. drop out) at each follow-up point. Change from baseline to 6-, 12-, 18- and 24-month follow up
Secondary Client's mental health The Zung Depression Scale will be used to measure clients' depressive symptoms. Drug avoidance self-efficacy will be measured with selected questions from the Drug Avoidance Self-Efficacy Scale (DASES). Change from baseline to 6-, 12-, 18- and 24-month follow up
Secondary Provider attitudes toward and interaction with clients Negative attitude toward drug users will be measured with questions adapted from the brief scale of attitude measurement developed by researchers at the National Centre for Education and Training on Addiction, Flinders University, Australia (2006). Provider-client interaction will be measured with 12 questions specifically developed for this study and tested in the pilot. Change from baseline to 6-, 12-, 18- and 24-month follow up
See also
  Status Clinical Trial Phase
Recruiting NCT05736588 - Elimisha HPV (Human Papillomavirus) N/A
Completed NCT04108078 - Promoting Reductions in Intersectional StigMa (PRISM) - GHANA N/A
Completed NCT01858493 - Continence Across Continents to Upend Stigma and Dependency N/A
Recruiting NCT01664884 - Internalized Stigma in Patients With Bipolar Disorder or Schizophrenia N/A
Completed NCT05489978 - Effectiveness of a Cervical Cancer Stigma Reduction Intervention Program on Cancer Stigma Score and Cervical Cancer Screening Uptake in Nepal N/A
Completed NCT06456710 - Effect of a Psychological Intervention on Stigma: a Randomized Controlled Study N/A
Completed NCT01571752 - Health Outcomes by Neighborhood - Baltimore
Recruiting NCT06010108 - Actions For Collaborative Community Engaged Strategies for HPV N/A
Active, not recruiting NCT03649776 - Training Church Leaders in Mental Health First Aid
Recruiting NCT05660148 - Influence of Resentment and Forgivingness on Quality of Life in People Living With HIV